FDA drug approval marks first for a disease — but it's not autism

Leucovorin is now approved to treat cerebral folate deficiency, months after FDA Commissioner Marty Makary claimed the decades-old generic drug had promise in treating autism. The FDA's review is based on published literature and real-world evidence.

The post FDA drug approval marks first appearance of a disease — but it’s not autism appeared first on MedCity News.